The CTSI Training Program in Translational Science (TPTS; formerly known as the UCLA K30 Program) was developed to provide clinicians with the necessary training to become successful patient-oriented investigators who can bridge molecular medicine and clinical research. Participants have a high commitment to clinical research and must have either professional health degrees (e.g., medicine, nursing, dentistry) or a doctorate. In addition, participants must be affiliated with UCLA, Harbor-LABioMed, Cedars-Sinai Medical Center or Charles R. Drew University of Medicine and Science (the CTSI partner institutions).
There is a separate program for medical students (Pathway in Clinical & Translational Research at UCLA).
TPTS is organized into three tracks:
The Medical Student Pathway in Clinical and Translational Science provides training for students at the David Geffen School of Medicine. Students enter the Pathway Program during their first or second year of medical school.
Track 1 and 2:
Medical Student Pathway in Clinical and Translational Research participants:
Admissions decisions will be made by our Admissions Subcommittee and approved by our Executive Committee using the following criteria: (1) scientific background, and (2) commitment to a career in patient-oriented translational investigation.
Track 1 courses are open for audit to fellows, faculty and medical students in the Medical Student Pathway Program. Audited courses are free, but no graduate credit is given. Courses may be taken for credit by paying fees through UCLA Extension.
In Track 1:
The curriculum is organized into seminar series, also referred to as seminar modules, about specific topics in clinical research. All seminars are presented at UCLA but are available via live videoconference at Cedars-Sinai, Harbor-UCLA/LABioMed, and Charles R. Drew University.
Note: Module topics and dates may vary from year to year. Dates will be posted as the modules are confirmed.
Please see Course Catalog for dates, times and locations of courses.
Track 2 is a structured, two-year certificate program that provides participants with the necessary training to become successful patient-oriented investigators who can bridge molecular medicine and clinical research. Participation in Track 2 is viewed favorably by K23 study sections.
To be eligible, you need:
Track 2 requirements:
Fees – Track 2 fellows audit courses, lectures and seminars. The audit option requires no fees, but no graduate credit is given. UCLA graduate courses may be taken for credit by registering and paying fees through UCLA Extension.
Location – All courses are at UCLA but are also available via videoconference at our partner sites. In addition, individuals may satisfy some program requirements by taking compatible courses at Cedars-Sinai Medical Center (CS) or Harbor-UCLA Medical Center (HU). These courses are identified in the "required coursework" accordion.
Track 2 fellows are required to complete four courses and two electives from the list below over two years. All courses are given at UCLA but are available by live video conference at our partner sites (with a few exceptions). In addition, individuals may satisfy some program requirements by taking compatible courses at Cedars-Sinai Medical Center (CS) or Harbor-UCLA Medical Center (HU).
Attendance in each class must not fall below 75-80%, depending on the class. Completing homework for grading is required for Biomath 170A and 266A, and passing a final take-home exam for a certificate of completion is required for Biomath M261.
Please see the UCLA Schedule of Classes for dates, times and locations of courses.
Sample Coursework Schedule
View a sample two-year coursework plan subject to change.
Track 2 fellows are required to attend monthly meetings until program completion and participate in three presentations. Monthly meetings are held on the third Tuesday of the month from 11:30 am - 1:00 pm. Lunch is provided. The meetings are designed to give trainees and opportunity to present their research in an open yet structured format during which they receive feedback from their peers, the Program Director, and faculty.
Three to four trainees present at each monthly meeting, using one of the following formats:
For their monthly meeting presentations, trainees may use one of the three formats explained below.
Every incoming trainee must do this presentation during their first year. Each trainee introduces himself/herself and gives a brief overview of his/her area of work and research proposal submitted with the Track 2 application (15-minutes, plus 5-minutes Q&A). Trainees are strongly encouraged to invite their research mentor(s) to attend. Other senior researchers in the trainee's area of study may be invited to attend the presentation at the discretion of Isidro Salusky MD, Program Director.
Each trainee selects an article relevant to his/her research and prepares to lead a discussion of the clinical or translational research methodology (20-minutes total).
This presentation should be reserved for the end of a trainee's second year (unless the trainee is completing the program in one year; in that case, they must do all three presentations in that first year). The goal of this assignment is to solicit input from trainees and faculty to help you address a problem that you are encountering in your research or professional development. Problems on which you might choose to focus include issues regarding resolution of disagreements with a collaborator or a mentor, concerns regarding career trajectory, an ethical dilemma, preventing over-committal to too many projects, finding ways to address critical reviews of a grant or manuscript, challenges encountered with gaps in training, difficulty with research budgets/funding, etc.
To prepare for this session, you will need to identify the challenge on which you would like to focus and develop a presentation of no longer than 4 minutes to briefly describe the situation. Narrow your question to the group if you find that you need significantly more time to describe the challenge. Once your BRIEF presentation is done, the group engages in the following process under the guidance of the faculty facilitator:
Discussant: A fellow discussant may be randomly assigned for each Journal Article and/or Challenge presentation. Discussant addresses such issues as clarity, importance of question, choice of research design, instrumentation, statistical analysis, and presentation of results (see also #3 above, under Journal Article).
Click here to view recordings of the most recently completed Track 2 and Track 3 courses from past quarters.
The Training Program in Translational Science Track 2 trainee list is being updated.
(by year training was completed)
|Naser Ahmadi, MD Harbor/UCLA WLA-VA General Medicine/Cardiology|
|Zaid Chaudhry MD UCLA/Olive View / Female Pelvic Medicine and Reconstructive Surgery|
|Seth Cohen MD UCLA / Urology|
|Dennis Montoya PhD UCLA/Molecular, Cell & Development Biology
|My-Linh Nguyen MD UCLA / Obstetrics & Gynecology|
|Jenny Dai-Ju MD PhD Harbor-UCLA/Endocrinology
|Luu Doan Ireland MD MPH UCLA/Family Planning
|Bob Geng MD MA UCLA/Allergy & Immunology
|David Gordon Charles R. Drew University of Medicine & Science
|Ivet Hartonian MD UCLA/Pediatric Neurology
|Kattayoun Kordy MD UCLA/Pediatric Gastroenterology, Hepatology & Nutrition
|Rajan Kulkarni MD PhD UCLA/Dermatology
|Sonya Pritzker PhD MA MS UCLA General Internal Medicine & Health Services Research
|Kumar C Shah BDS MS FACP UCLA School of Dentistry
|Nelly Tan MD, UCLA/Radiology
|Peter Tieh MD Harbor-UCLA/Pediatric Endocrinology
|Maida Wong MD UCLA Rheumatology
|Joshua G. Cohen MD UCLA/Cedars-Sinai Medical Center/Oncology
|Satiro De Oliveira MD UCLA Pediatric Hematology/Oncology
|Mary T. Jenkins Vogel MD Cedars-Sinai Medical Center/Gynecologic Oncology
|Caron Kim MD MSc UCLA/Obstetrics & Gynecology
Veronica Sullins MD Harbor-UCLA Surgery
|Eric Yen MD UCLA Rheumatology/Pediatrics
|Kelly Callahan, MD Harbor-UCLA/Pediatrics|
|Marissa Caudill, MD PhD UCLA, Child Psychiatry|
|Fnu Deepinder, MD Cedars Sinai—WLA-VA Endocrinology|
|Catherine DeRidder, MD Harbor-UCLA/Pediatrics/Child Abuse|
|Elena Diaz MD Cedars-Sinai Medical Center/Gynecologic Oncology
|Andrew Dorsch, MD UCLA/Neurology|
|Joshua Grill, PhD UCLA Director, Katherine and Benjamin Kagan Alzheimer's Disease Treatment Development Program
Director, Recruitment and Education Core Mary S. Easton Center for Alzheimer's Disease Research
|Jane Kuo, MD Cedars-Sinai/Medical Genetics|
|Dong Li, MD PhD Harbor-UCLA/Genetic Epidemiology|
|Geoffry Sonn MD UCLA/Urology
|Neha Vaghasia, MD UCLA/Pediatrics-Hematology & Oncology|
|Ali Alktaifi, MD UCLA Department of Surgery|
|Rebecca Hicks, MD Harbor/UCLA Pediatric Endocrinology|
|Bahram Khazai, MD Harbor/UCLA Internal Medicine/Endocrinology
|Christina Lam, MD UCLA/Pediatrics and Medical Genetics
|Frank Shih-Chang Ong, MD Cedars Sinai Pathology & Laboratory Medicine|
|Lisa Rogo-Gupta, MD UCLA/Femal Pelvic Medicine & Reconstructive Surgery
|Anita Rowhani Sicolo, MD UCLA Pediatric Gastroenterology Fellow
|Prasanth N. Surampudi, MD Harbor UCLA T32 Endocrinology Fellow
|Sigrid Burruss, MD UCLA Department/General Surgery|
|William A. Freije, MD, PhD UCLA Department of OB &GYN|
|Michelle Gardner, PhD MS UCLA Department of Orthopedic Surgery|
|Jethro L. Hu, MD Cedars-Sinai Medical Center Neuro-Oncology|
|Niloufar Ilani, MD Harbor-UCLA Medical Center Endocrinology|
|Po H. Lu, PsyD UCLA Department of Neurology|
|James A. McKinnell, MD Harbor-UCLA Medical Center Infectious Diseases|
|Denise D. Nicholson, AuD UCLA Audiology Clinic|
|David E. Piccioni, MD, PhD UCLA Department of Neurology|
|Laura Wozniak, MD UCLA Pediatric Gastroenterology/Hepatology/Nutrition|
|Z. Chad Baxter, MD UCLA Pelvic Medicine/Urology|
|Agnes Huang Chen, MD Harbor-UCLA Medical Center Pediatrics and Neurology|
|Daniel DeUgarte, MD UCLA Pediatrics/Bariatric and Metabolic Surgery|
|Noah Federman, MD UCLA Pediatric/Hematology-Oncology|
|Alan Ikeda, MD UCLA Pediatric/ Hematology-Oncology|
|Larissa Mooney, MD UCLA Semel Institute for Neuroscience and Human Behavior/Integrated Substance Abuse|
|Mary Elizabeth Patterson, MD Harbor-UCLA Endocrinolog|
|Thomas Thannickal, PhD UCLA Department of Psychiatry and Behavioral Sciences|
|Farin Amersi, MD Cedars-Sinai Medical Center Department of Surgery, Division of Surgical Oncology|
|David Andorsky, MD UCLA Medicine, Division of Hematology & Oncology|
|Alice Chang, MD UCLA Pediatric Rheumatology|
|David Chim, DO UCLA Semel Institute for Neuroscience and Human Behavior/Integrated Substance Abuse|
|Sherilyn Gordon Burroughs, MD UCLA Division of Liver and Pancreas Transplantation, Department of Surgery|
|Phuong Thao Hoang, MD David Geffen School of Medicine at UCLA Department of Pediatrics, Division of Pediatric Endocrinology|
|Mariko Ishimori, MD Cedars-Sinai Medical Center Medicine, Division of Rheumatology|
|Philip Liu, PhD UCLA Department of Microbiology, Immunology, and Molecular Genetics|
|Daniel Margolis, MD UCLA Radiological Sciences|
|Rodney McKeever, MD, FCCP King/Drew Medical Center Critical Care Medicine, Transfusion Medicine|
|Jennifer Yee, MD Harbor-UCLA Medical Center Pediatric Endocrinology|
|Marc Brodksy, MD, MBA UCLA Center for East-West Medicine|
|John David Carmichael, MD Cedars-Sinai Medical Center Department of Endocrinology and Metabolism|
|Yoon-Hee Cha, MD UCLA Department of Neurology|
|Dinesh Chhetri, MD UCLA Department of Surgery/Otolaryngology|
|Lorraine Evangelista, PhD, RN UCLA School of Nursing|
|James Farrell, MD UCLA Division of Digestive Diseases|
|Karen Hamill, DPT UCLA Rehabilitation Services|
|Joseph L. Lasky, III, MD UCLA Pediatric Neuro-oncology|
|Nerses Sanossian, MD Keck School of Medicine at USC Department of Neurology|
|Anil Sharma, MD, MBA UCLA Semel Institure for Neuroscience & Human Behavior|
|Stephen B. Shew, MD UCLA Surg-Ped|
|Brian Shuch, MD UCLA Urology|
|Malcolm Taw, MD UCLA Center for East-West Medicine|
|Raymond Wang, MD Children's Hospital of Orange County Biochemical Genetics|
||Katherine Wesseling, MD UCLA Department of Pediatric Nephrology|
|Ana Isabel Alvarez-Retuerto, PhD UCLA Department of Psychiatry|
|Mitali Wadekar, MD UCLA Neuropsychiatric Institute (NPI)|
||Eric Crombez, MD UCLA Department of Pediatrics, Division of Medical Genetics|
||Sarah E. Evans, PhD UCLA Semel Institute of Neuroscience and Behavior|
|Cynthia Hall, MD, FACOG UCLA/Cedars-Sinai Medical Center Obstetrics and Gynecology/Urogynecology and Pelvic Reconstructive Surgery|
||Isett Laux, PhD Cedars-Sinai Medical Center Prostate Cancer Center|
|Joann Lin, MD UCLA Department of Pediatrics, Division of Allergy and Immunology|
|Michael Milane, MD, MPH UCLA Semel Institute for Neuroscience and Human Behavior|
||Phioanh Nghiemphu, MD UCLA Department of Neurology|
|Raquel Soto, MD Harbor-UCLA Medical Center Department of Family Medicine/Health Education Center|
||Preethi Srikanthan, MD UCLA Division of Clinical Epidemiology and Preventive Medicine|
|Odelia Cooper, MD Cedars-Sinai Medical Center Department of Endocrinology and Metabolism|
||Jonathan Cotliar, MD UCLA Division of Dermatology|
||Deborah Flores, MD Harbor-UCLA Medical Center Department of Psychiatry & Biobehavorial Sciences|
||Jordan Geller, MD Cedars-Sinai Medical Center Division of Endocrinology|
|Carla Janzen, MD, PhD UCLA Department of Obstetrics and Gynecology|
|John Lam, MD UCLA Department of Urology|
|Halleh Mir, MD UCLA Department of Pediatrics, Division of Neonatology|
|Pornpimol Rianthavorn, MD|
|Noriko Salamon, MD, PhD UCLA Department of Radiology|
|Rosa Solorio, MD, MPH UCLA Department of Family Medicine|
||Bulent Yildiz, MD|
|David Ziring, MD UCLA Division of Pediatric Gastroenterology|
|Heather Cahan, MD Private Pediatrics/Neonatology|
||Barbara Gitlitz, MD USC Clinical Medicine/Lung, Head and Neck Program|
Track 2 admissions application period is open from February 1 to May 15 for the academic year beginning August 1.
Applicants need to be prepared to electronically submit in .doc or .pdf format:
*Letters of recommendation and support from 1) your department chair/chief or immediate supervisor, and 2) mentor(s) may also be e-mailed to the Program Coordinator at firstname.lastname@example.org. One letter must include a statement from the applicant's department head or supervisor that confirms that the applicant will be given secure protected time to complete the two-year certificate program curriculum.
Track 3 leads to a Master of Science in Clinical Research graduate degree. The program is designed to train fellows and faculty to:
The program takes two years to complete for full-time (minimum 70%) participants. STAR fellows are expected to take three years so they may submit manuscripts and apply for a K23 and transition to a faculty position. Faculty with clinical duties may take three years or more.
Track 3 MSCR participants must:
Applications are accepted Feb 1 to May 15 for the next academic year that begins in Sept/Oct (Fall Quarter).
Track 3 MSCR graduate students must complete a specified curriculum and a research project.
Students must complete a minimum of 48 units, including:
Mentored Research Project
Required courses are listed below. All required courses are held at UCLA, but are available via live videoconference at Cedars-Sinai, LABiomed/Harbor-UCLA Medical Center, and Charles R. Drew University of Medicine and Science.
Please see the UCLA Schedule of Classes for dates, times, and locations of classes.
Fellows must take a total of 8-units of graduate elective courses (200 series), typically in the second year of the program. Electives may include but are not limited to epidemiology, health services, or basic science courses.
Sample Coursework Schedule
View a sample two-year coursework plan subject to change.
Click here to view recordings of the most recently completed Track 2 and Track 3 courses from past quarters.
Upon acceptance to Track 3 MSCR, participants must apply directly for admission to the UCLA Graduate Division. Track 3 student stipends and fees are supported by their home departments; admission to the program requires a letter of commitment for this support from the student's clinical department chair.
UCLA non-academic-senate employees with appointments of at least 50% may receive a two-thirds reduction in fees. See Procedure 51—Reduced Fee Enrollment
Applicants from UCLA partner affiliates may be eligible for shared tuition support from the CTSI.
Fees are subject to revision without notice. To view the current fee schedule, click here.
Applications are accepted Feb 1 to May 15 for academic year that begins Sept/Oct (Fall Quarter).
* * *
IMPORTANT: Applicants need to arrange a meeting or telephone appointment with Dr. Veena Ranganath, the Co-Director, before submitting a Track 3 MSCR application and before submitting an application to UCLA Graduate Division. Email Dr. Ranganath
The Track 3 MSCR application instructions and application cover page can be accessed by clicking on the "apply now" icon below or click here.
Application Packet Submission
Please email your application packet, as a PDF, to:
UCLA David Geffen School of Medicine
CTSI Student Affairs
*Transcripts: May be mailed to the following address, or email official "e-transcripts" to email@example.com.
David Geffen School of Medicine at UCLA
PO Box 957396
Los Angeles, California, 90095-7396
Questions about the application process may be addressed to the TPTS Coordinator at firstname.lastname@example.org.
Application to Graduate Division
After an applicant receives confirmation of acceptance into the MSCR program (and only then), they complete the online UCLA Application for Graduate Admission (grad.ucla.edu).
The Medical Student Pathway in Clinical and Translational Science provides training for students at the David Geffen School of Medicine. Students enter the Pathway program during their first or second year of medical school.
Students who complete the Pathway receive mention of the Pathway in the Medical Student Performance Evaluation (MSPE) Dean’s Letter.
MD/PhD candidates are not eligible for the Pathway program.
The Pathway in Clinical and Translational Science is completed during the four years of medical school and includes course and research requirements. Students must provide an annual progress report to the Pathway office, including publications and presentations, or any change in mentorship. Completion of a pre- and post- training online survey is also required.
Interested medical students may contact the Pathway Program administrator, at email@example.com.
Applicants will be asked to email:
What if I want to participate in some of the Pathway activities but not all of them?
You can participate in any of the listed activities without being in the Pathway. In addition, continued enrollment in the Pathways program is voluntary. Students who do complete the requirements will receive a Certificate of Completion and mention of the Pathway in the Medical Student Perfomance Evaluation (MSPE) Dean's letter.
How can I best go about identifying a research mentor?
Dr. Isidro Salusky will meet with you once you have decided to join the Pathway to discuss your specific interests and to identify several faculty members working in areas that you might want to contact. You should also find the Selectives useful in meeting potential mentors from among the faculty. Finally, the Pathway also hosts student/faculty mixers as another source of identifying mentors.
I did not join the Pathway during my first year of medical school. Is it too late to join in year 2?
If you participated in a clinical or translational research experience for a minimum of 6 weeks in the summer between your 1st and 2nd year of medical school, you can still meet all of the requirements for the Pathway. All of the Pathway activities are open to you even without enrolling in the Pathways program. What is not possible is completing the Certificate requirements without this critical summer research experience between M1 and M2 years.
I plan to apply to one of the joint degree programs. Does this mean that the Pathway is unnecessary?
The School of Medicine has joint or articulated degree programs with the School of Public Health, the Luskin School of Public Affairs, or the Anderson School of Management. You would apply for any of these during your 3rd year of medical school. Each of these programs is designed to strengthen your skills in research design and requires completion of a scholarly project. We believe that a year of intensive study towards one of these additional degrees will be extremely useful in preparing for a research career. Participation in the Pathway could assist you in making the decision about what dual degree to pursue, but obtaining a Certificate in this instance might be less important.
I do not want to join the Academic Medicine College. Can I still be in the Pathway?
There are two other ways to meet the requirement for research training during Year 4. One is to participate in a combination of clinical research development seminar modules and/or relevant evening seminars from the Academic Medicine College (as identified by the Pathway program faculty) based on the current topic schedule of each. Another is to attend a week long clinical and translational research workshop sponsored by UCLA and Cedars-Sinai Medical Center and held in July.
What can I do if I cannot attend a seminar module lecture?
If due to class and other scheduling conflicts, you are unable to attend a seminar module lecture, please note that video recordings and lecture slides are available online! As identified by the Pathway program faculty, you may get program credit by watching these online and completing the following:
UCLA CCLE - CTSI course management site
TPTS students who have been officially added to a course (enrolled or auditing) can access schedules, notices, and materials through UCLA CCLE.
Login information: Once you have been added to a course, it will appear under Class Sites when you log into CCLE using your UCLA logon ID. If you are using guest access, you will not be able to view most of the course content. If you do not have a UCLA Login ID, you will be able to create one, even if you are not a UCLA faculty, fellow, or student.
CTSI Training Program Director
Isidro B. Salusky MD
office: (310) 206-6987
Track 3 MSCR Co-Director/Faculty Advisor
Veena Ranganath, MD, MS, RhMSUS
office: (310) 825-3061
CTSI Training Program Coordinator
office: (310) 825-6312